Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society.

Epilepsia Open. 2018 May 21;3(2):175-192. doi: 10.1002/epi4.12225. eCollection 2018 Jun.

2.

Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.

Pfeifer H, Raum K, Markovic S, Nowak V, Fey S, Obländer J, Pressler J, Böhm V, Brüggemann M, Wunderle L, Hüttmann A, Wäsch R, Beck J, Stelljes M, Viardot A, Lang F, Hoelzer D, Hofmann WK, Serve H, Weiss C, Goekbuget N, Ottmann OG, Nowak D.

Blood. 2018 Mar 29;131(13):1464-1475. doi: 10.1182/blood-2017-07-796862. Epub 2018 Jan 18.

PMID:
29348129
3.
4.

Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy.

Nagel I, Bartels M, Duell J, Oberg HH, Ussat S, Bruckmueller H, Ottmann O, Pfeifer H, Trautmann H, Gökbuget N, Caliebe A, Kabelitz D, Kneba M, Horst HA, Hoelzer D, Topp MS, Cascorbi I, Siebert R, Brüggemann M.

Blood. 2017 Nov 2;130(18):2027-2031. doi: 10.1182/blood-2017-05-782888. Epub 2017 Aug 21.

5.

Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital.

Grocott OR, Herrington KS, Pfeifer HH, Thiele EA, Thibert RL.

Epilepsy Behav. 2017 Mar;68:45-50. doi: 10.1016/j.yebeh.2016.12.018. Epub 2017 Jan 19.

PMID:
28109989
6.

Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.

Ebinger S, Özdemir EZ, Ziegenhain C, Tiedt S, Castro Alves C, Grunert M, Dworzak M, Lutz C, Turati VA, Enver T, Horny HP, Sotlar K, Parekh S, Spiekermann K, Hiddemann W, Schepers A, Polzer B, Kirsch S, Hoffmann M, Knapp B, Hasenauer J, Pfeifer H, Panzer-Grümayer R, Enard W, Gires O, Jeremias I.

Cancer Cell. 2016 Dec 12;30(6):849-862. doi: 10.1016/j.ccell.2016.11.002. Epub 2016 Dec 1.

7.

Design of a quasi-2D photonic crystal optomechanical cavity with tunable, large x<sup>2</sup>-coupling.

Kalaee M, Paraïso TK, Pfeifer H, Painter O.

Opt Express. 2016 Sep 19;24(19):21308-28. doi: 10.1364/OE.24.021308.

PMID:
27661874
8.

Design of tunable GHz-frequency optomechanical crystal resonators.

Pfeifer H, Paraïso T, Zang L, Painter O.

Opt Express. 2016 May 30;24(11):11407-19. doi: 10.1364/OE.24.011407.

PMID:
27410069
9.

Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.

Oelsner S, Wagner J, Friede ME, Pfirrmann V, Genßler S, Rettinger E, Buchholz CJ, Pfeifer H, Schubert R, Ottmann OG, Ullrich E, Bader P, Wels WS.

Int J Cancer. 2016 Oct 15;139(8):1799-809. doi: 10.1002/ijc.30217. Epub 2016 Jun 11.

10.

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.

Rousselot P, Coudé MM, Gokbuget N, Gambacorti Passerini C, Hayette S, Cayuela JM, Huguet F, Leguay T, Chevallier P, Salanoubat C, Bonmati C, Alexis M, Hunault M, Glaisner S, Agape P, Berthou C, Jourdan E, Fernandes J, Sutton L, Banos A, Reman O, Lioure B, Thomas X, Ifrah N, Lafage-Pochitaloff M, Bornand A, Morisset L, Robin V, Pfeifer H, Delannoy A, Ribera J, Bassan R, Delord M, Hoelzer D, Dombret H, Ottmann OG; European Working Group on Adult ALL (EWALL) group.

Blood. 2016 Aug 11;128(6):774-82. doi: 10.1182/blood-2016-02-700153. Epub 2016 Apr 27.

11.

Evaluation and modelling of dissolved organic matter reactivity toward As(III) and As(V) – implication in environmental arsenic speciation.

Lenoble V, Dang DH, Loustau Cazalet M, Mounier S, Pfeifer HR, Garnier C.

Talanta. 2015 Mar;134:530-537. doi: 10.1016/j.talanta.2014.11.053. Epub 2014 Dec 9.

PMID:
25618704
12.

The use of solid-phase fluorescence spectroscopy in the characterisation of organic matter transformations.

Albrecht R, Verrecchia E, Pfeifer HR.

Talanta. 2015 Mar;134:453-459. doi: 10.1016/j.talanta.2014.11.056. Epub 2014 Dec 3.

PMID:
25618693
13.

Fluorescence spectroscopy to study dissolved organic matter interactions with agrochemicals applied in Swiss vineyards.

Daouk S, Frege C, Blanc N, Mounier S, Redon R, Merdy P, Lucas Y, Pfeifer HR.

Environ Sci Pollut Res Int. 2015 Jun;22(12):9284-92. doi: 10.1007/s11356-015-4086-6. Epub 2015 Jan 17.

PMID:
25592914
14.

Human exposure to mercury in artisanal small-scale gold mining areas of Kedougou region, Senegal, as a function of occupational activity and fish consumption.

Niane B, Guédron S, Moritz R, Cosio C, Ngom PM, Deverajan N, Pfeifer HR, Poté J.

Environ Sci Pollut Res Int. 2015 May;22(9):7101-11. doi: 10.1007/s11356-014-3913-5. Epub 2014 Dec 12.

PMID:
25501641
15.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, Trapmann S, Aggerholm A, Andrikovics H, Akiki S, Barbany G, Boeckx N, Bench A, Catherwood M, Cayuela JM, Chudleigh S, Clench T, Colomer D, Daraio F, Dulucq S, Farrugia J, Fletcher L, Foroni L, Ganderton R, Gerrard G, Gineikienė E, Hayette S, El Housni H, Izzo B, Jansson M, Johnels P, Jurcek T, Kairisto V, Kizilors A, Kim DW, Lange T, Lion T, Polakova KM, Martinelli G, McCarron S, Merle PA, Milner B, Mitterbauer-Hohendanner G, Nagar M, Nickless G, Nomdedéu J, Nymoen DA, Leibundgut EO, Ozbek U, Pajič T, Pfeifer H, Preudhomme C, Raudsepp K, Romeo G, Sacha T, Talmaci R, Touloumenidou T, Van der Velden VH, Waits P, Wang L, Wilkinson E, Wilson G, Wren D, Zadro R, Ziermann J, Zoi K, Müller MC, Hochhaus A, Schimmel H, Cross NC, Emons H.

Leukemia. 2015 Feb;29(2):369-76. doi: 10.1038/leu.2014.217. Epub 2014 Jul 18.

16.

Generation and subwavelength focusing of longitudinal magnetic fields in a metallized fiber tip.

Ploss D, Kriesch A, Pfeifer H, Banzer P, Peschel U.

Opt Express. 2014 Jun 2;22(11):13744-54. doi: 10.1364/OE.22.013744.

PMID:
24921567
17.

Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.

Terwey TH, Hemmati PG, Nagy M, Pfeifer H, Gökbuget N, Brüggemann M, Le Duc TM, le Coutre P, Dörken B, Arnold R.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1522-9. doi: 10.1016/j.bbmt.2014.05.026. Epub 2014 Jun 4.

18.

Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.

Schaab C, Oppermann FS, Klammer M, Pfeifer H, Tebbe A, Oellerich T, Krauter J, Levis M, Perl AE, Daub H, Steffen B, Godl K, Serve H.

Leukemia. 2014 Mar;28(3):716-9. doi: 10.1038/leu.2013.347. Epub 2013 Nov 19. No abstract available.

19.

Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia.

Badura S, Tesanovic T, Pfeifer H, Wystub S, Nijmeijer BA, Liebermann M, Falkenburg JH, Ruthardt M, Ottmann OG.

PLoS One. 2013 Nov 14;8(11):e80070. doi: 10.1371/journal.pone.0080070. eCollection 2013.

20.

Functional plasmonic nanocircuits with low insertion and propagation losses.

Kriesch A, Burgos SP, Ploss D, Pfeifer H, Atwater HA, Peschel U.

Nano Lett. 2013 Sep 11;13(9):4539-45. doi: 10.1021/nl402580c. Epub 2013 Aug 23.

21.
22.

The herbicide glyphosate and its metabolite AMPA in the Lavaux vineyard area, Western Switzerland: proof of widespread export to surface waters. Part I: method validation in different water matrices.

Daouk S, Grandjean D, Chevre N, De Alencastro LF, Pfeifer HR.

J Environ Sci Health B. 2013;48(9):717-24. doi: 10.1080/03601234.2013.780535.

PMID:
23688222
23.

Dynamics and environmental risk assessment of the herbicide glyphosate and its metabolite AMPA in a small vineyard river of the Lake Geneva catchment.

Daouk S, Copin PJ, Rossi L, Chèvre N, Pfeifer HR.

Environ Toxicol Chem. 2013 Sep;32(9):2035-44. doi: 10.1002/etc.2276. Epub 2013 Jul 12.

PMID:
23661498
24.

Room for improvement.

Pfeifer HW.

Dtsch Arztebl Int. 2013 Feb;110(7):116. doi: 10.3238/arztebl.2013.0116a. Epub 2013 Feb 15. No abstract available.

25.

Trace metal and metalloid contamination levels in soils and in two native plant species of a former industrial site: evaluation of the phytostabilization potential.

Testiati E, Parinet J, Massiani C, Laffont-Schwob I, Rabier J, Pfeifer HR, Lenoble V, Masotti V, Prudent P.

J Hazard Mater. 2013 Mar 15;248-249:131-41. doi: 10.1016/j.jhazmat.2012.12.039. Epub 2012 Dec 29.

PMID:
23352904
26.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Pfeifer H, Wassmann B, Bethge W, Dengler J, Bornhäuser M, Stadler M, Beelen D, Vucinic V, Burmeister T, Stelljes M, Faul C, Dreger P, Kiani A, Schäfer-Eckart K, Schwerdtfeger R, Lange E, Kubuschok B, Horst HA, Gramatzki M, Brück P, Serve H, Hoelzer D, Gökbuget N, Ottmann OG; GMALL Study Group.

Leukemia. 2013 Jun;27(6):1254-62. doi: 10.1038/leu.2012.352. Epub 2012 Dec 5.

PMID:
23212150
27.

Dietary management of epilepsy.

Hsieh DT, Pfeifer HH, Thiele EA.

Am Fam Physician. 2012 Dec 1;86(11):1000-1. No abstract available.

28.

[Small renal mass].

Prokofiev D, Kreutzer N, Kress A, Wissing F, Pfeifer H, Stolzenburg JU, Dietel A, Schwalenberg T, Do M, Truß MC.

Urologe A. 2012 Oct;51(10):1459-65; quiz 1466-8. doi: 10.1007/s00120-012-2960-0. German.

PMID:
23053040
29.

Low glycemic index treatment for seizures in Angelman syndrome.

Thibert RL, Pfeifer HH, Larson AM, Raby AR, Reynolds AA, Morgan AK, Thiele EA.

Epilepsia. 2012 Sep;53(9):1498-502. doi: 10.1111/j.1528-1167.2012.03537.x. Epub 2012 Jul 10.

30.

Carnitine, nutritional supplementation and discontinuation of ketogenic diet therapies.

Neal EG, Zupec-Kania B, Pfeifer HH.

Epilepsy Res. 2012 Jul;100(3):267-71. doi: 10.1016/j.eplepsyres.2012.04.021. Epub 2012 Jun 15. Review.

PMID:
22704584
31.

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.

Pfeifer H, Lange T, Wystub S, Wassmann B, Maier J, Binckebanck A, Giagounidis A, Stelljes M, Schmalzing M, Dührsen U, Wunderle L, Serve H, Brück P, Schmidt A, Hoelzer D, Ottmann OG.

Leukemia. 2012 Jul;26(7):1475-81. doi: 10.1038/leu.2012.5. Epub 2012 Jan 9.

PMID:
22230800
32.

Low glycemic index treatment for epilepsy in tuberous sclerosis complex.

Larson AM, Pfeifer HH, Thiele EA.

Epilepsy Res. 2012 Mar;99(1-2):180-2. doi: 10.1016/j.eplepsyres.2011.10.021. Epub 2011 Nov 25.

PMID:
22119636
33.

Deconvolution of the density of states of tip and sample through constant-current tunneling spectroscopy.

Pfeifer H, Koslowski B, Ziemann P.

Beilstein J Nanotechnol. 2011;2:607-17. doi: 10.3762/bjnano.2.64. Epub 2011 Sep 19.

34.

The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms.

Numis AL, Yellen MB, Chu-Shore CJ, Pfeifer HH, Thiele EA.

Epilepsy Res. 2011 Sep;96(1-2):172-5. doi: 10.1016/j.eplepsyres.2011.05.012. Epub 2011 Jun 22.

PMID:
21700429
35.

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Topp MS, Kufer P, Gökbuget N, Goebeler M, Klinger M, Neumann S, Horst HA, Raff T, Viardot A, Schmid M, Stelljes M, Schaich M, Degenhard E, Köhne-Volland R, Brüggemann M, Ottmann O, Pfeifer H, Burmeister T, Nagorsen D, Schmidt M, Lutterbuese R, Reinhardt C, Baeuerle PA, Kneba M, Einsele H, Riethmüller G, Hoelzer D, Zugmaier G, Bargou RC.

J Clin Oncol. 2011 Jun 20;29(18):2493-8. doi: 10.1200/JCO.2010.32.7270. Epub 2011 May 16.

PMID:
21576633
36.

Substance flow analysis as a tool for urban water management.

Chèvre N, Guignard C, Rossi L, Pfeifer HR, Bader HP, Scheidegger R.

Water Sci Technol. 2011;63(7):1341-8. doi: 10.2166/wst.2011.132.

PMID:
21508535
37.

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Østergaard M, Nyvold CG, Jovanovic JV, Andersen MT, Kairisto V, Morgan YG, Tobal K, Pallisgaard N, Ozbek U, Pfeifer H, Schnittger S, Grubach L, Larsen JK, Grimwade D, Hokland P.

Leukemia. 2011 Jul;25(7):1168-73. doi: 10.1038/leu.2011.69. Epub 2011 Apr 15.

PMID:
21494256
38.

Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.

Sellner L, Capper D, Meyer J, Langhans CD, Hartog CM, Pfeifer H, Serve H, Ho AD, Okun JG, Krämer A, Von Deimling A.

Eur J Haematol. 2010 Nov;85(5):457-9. doi: 10.1111/j.1600-0609.2010.01505.x. No abstract available.

PMID:
20659156
39.

Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy.

Paul E, Conant KD, Dunne IE, Pfeifer HH, Lyczkowski DA, Linshaw MA, Thiele EA.

Epilepsy Res. 2010 Jun;90(1-2):151-6. doi: 10.1016/j.eplepsyres.2010.04.005. Epub 2010 May 13.

40.

Atmospheric deposition and migration of artificial radionuclides in Alpine soils (Val Piora, Switzerland) compared to the distribution of selected major and trace elements.

Chawla F, Steinmann P, Pfeifer HR, Froidevaux P.

Sci Total Environ. 2010 Jul 15;408(16):3292-302. doi: 10.1016/j.scitotenv.2010.03.012. Epub 2010 Apr 24.

PMID:
20417956
41.

Paul Tournier and 'Médecine de la Personne'-The man and his vision.

Pfeifer HR.

Int J Integr Care. 2010 Jan 29;10 Suppl:e022. No abstract available.

42.

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cavé H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ; European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); International Berlin-Frankfurt-Münster Study Group (I-BFM-SG).

Leukemia. 2010 Mar;24(3):521-35. doi: 10.1038/leu.2009.268. Epub 2009 Dec 24. Review.

PMID:
20033054
43.

Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Ottmann OG, Pfeifer H.

Hematology Am Soc Hematol Educ Program. 2009:371-81. doi: 10.1182/asheducation-2009.1.371.

PMID:
20008223
44.

First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults.

Ottmann OG, Pfeifer H.

Curr Opin Oncol. 2009 Jun;21 Suppl 1:S43-6. doi: 10.1097/01.cco.0000357476.43164.6b. Review.

PMID:
19561414
45.

Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy.

Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA.

Epilepsia. 2009 May;50(5):1118-26. doi: 10.1111/j.1528-1167.2008.01959.x. Epub 2009 Feb 12.

46.

Low glycemic index treatment: implementation and new insights into efficacy.

Pfeifer HH, Lyczkowski DA, Thiele EA.

Epilepsia. 2008 Nov;49 Suppl 8:42-5. doi: 10.1111/j.1528-1167.2008.01832.x. Review.

47.

Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group.

Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Helen Cross J, Dahlin MG, Donner EJ, Klepper J, Jehle RS, Kim HD, Christiana Liu YM, Nation J, Nordli DR Jr, Pfeifer HH, Rho JM, Stafstrom CE, Thiele EA, Turner Z, Wirrell EC, Wheless JW, Veggiotti P, Vining EP; Charlie Foundation, Practice Committee of the Child Neurology Society; Practice Committee of the Child Neurology Society; International Ketogenic Diet Study Group.

Epilepsia. 2009 Feb;50(2):304-17. doi: 10.1111/j.1528-1167.2008.01765.x. Epub 2008 Sep 23.

48.

Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR.

Pelz-Ackermann O, Cross M, Pfeifer H, Deininger M, Wang SY, Al-Ali HK, Niederwieser D, Lange T.

Leukemia. 2008 Dec;22(12):2288-91. doi: 10.1038/leu.2008.180. Epub 2008 Jul 10. No abstract available.

PMID:
18615107
49.

An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.

Müller MC, Saglio G, Lin F, Pfeifer H, Press RD, Tubbs RR, Paschka P, Gottardi E, O'Brien SG, Ottmann OG, Stockinger H, Wieczorek L, Merx K, König H, Schwindel U, Hehlmann R, Hochhaus A.

Haematologica. 2007 Jul;92(7):970-3.

50.

Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements.

Saldanha J, Silvy M, Beaufils N, Arlinghaus R, Barbany G, Branford S, Cayuela JM, Cazzaniga G, Gonzalez M, Grimwade D, Kairisto V, Miyamura K, Lawler M, Lion T, Macintyre E, Mahon FX, Muller MC, Ostergaard M, Pfeifer H, Saglio G, Sawyers C, Spinelli O, van der Velden VH, Wang JQ, Zoi K, Patel V, Phillips P, Matejtschuk P, Gabert J.

Leukemia. 2007 Jul;21(7):1481-7. Epub 2007 May 3.

PMID:
17476280

Supplemental Content

Loading ...
Support Center